Cargando…

Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma

BACKGROUND: The safety and tolerability of sequential radioembolization-sorafenib therapy is unknown. An open-label, single arm, investigator-initiated Phase II study (NCT0071279) was conducted at four Asia-Pacific centers to evaluate the safety and efficacy of sequential radioembolization-sorafenib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Pierce K. H., Poon, Donald Y. H., Khin, Maung-Win, Singh, Harjit, Han, Ho-Seong, Goh, Anthony S. W., Choo, Su-Pin, Lai, Hee-Kit, Lo, Richard H. G., Tay, Kiang-Hiong, Lim, Teong-Guan, Gandhi, Mihir, Tan, Say-Beng, Soo, Khee-Chee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948695/ https://www.ncbi.nlm.nih.gov/pubmed/24614178 http://dx.doi.org/10.1371/journal.pone.0090909

Ejemplares similares

Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial
por: Gandhi, Mihir, et al.
Publicado: (2016)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
por: Kao, Yung Hsiang, et al.
Publicado: (2014)

Non-Target Activity Detection by Post-Radioembolization Yttrium-90 PET/CT: Image Assessment Technique and Case Examples
por: Kao, Yung Hsiang, et al.
Publicado: (2014)

Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib
por: Rana, Nitesh, et al.
Publicado: (2013)

Interventional Radiology Preparedness in the Time of the COVID-19 Pandemic: Is there a Gold Standard?
por: Tan, Bien-Soo, et al.
Publicado: (2020)

Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab
por: Adcock, Charles S, et al.
Publicado: (2019)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020)

Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
por: Liu, Bao-Jiang, et al.
Publicado: (2020)

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

The physics of radioembolization
por: Bastiaannet, Remco, et al.
Publicado: (2018)

Short term clinical outcomes of accelerated hypofractionated radiotherapy in inoperable non-small cell lung cancer patients
por: Aye, Shoon Mya, et al.
Publicado: (2021)

Congenital renal arteriovenous malformation presenting with gross hematuria after a routine jog: a case report
por: Dames, Erin L, et al.
Publicado: (2014)

Large Pelvic Arteriovenous Malformation – A Bloody Near Miss
por: Linn, Yun Le, et al.
Publicado: (2021)

Case Report of Ethanol and Cyanoacrylate Embolisation of a Recurrent Uncontrollable Torrentially Bleeding Arteriovenous Malformation of the Finger
por: Aw, Darius K.L., et al.
Publicado: (2018)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
por: Öcal, Osman, et al.
Publicado: (2022)

Reassessment of the lung dose limits for radioembolization
por: Kappadath, S. Cheenu, et al.
Publicado: (2021)

The New Normal for IR Post COVID-19 Pandemic: Are the Goalposts Constantly Shifting?
por: Lee, Kristen Alexa, et al.
Publicado: (2022)

Repeated radioembolization in advanced liver cancer
por: Masthoff, Max, et al.
Publicado: (2020)

Inoperable Cancer
Publicado: (1901)

Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
por: Kim, Pyeong Hwa, et al.
Publicado: (2019)

Hepatic Radioembolization as a Bridge to Liver Surgery
por: Braat, Arthur J. A. T., et al.
Publicado: (2014)

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials
por: Gebski, Val, et al.
Publicado: (2017)

A New Treatment for Inoperable Cancer of the Breast
por: Leaf, Cecil H.
Publicado: (1901)

Radioembolization treatment for liver metastases
por: Kiszkaą, Joanna, et al.
Publicado: (2017)

Radioembolization for the treatment of hepatocellular carcinoma
por: Kim, Hyo-Cheol
Publicado: (2017)

Combining Immunotherapy with Transarterial Radioembolization
por: Balaban Genc, Zeynep Ceren, et al.
Publicado: (2023)

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
por: Huynh, Hung, et al.
Publicado: (2009)

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
por: Chung, Sung Won, et al.
Publicado: (2023)

Spontaneous spinal epidural haematoma following intra-arterial catheter-directed thrombolysis: A case report
por: Shannon, Nicholas Brian, et al.
Publicado: (2020)

Thyroidectomy in Inoperable Cancer
Publicado: (1909)

Treatment of Inoperable Cancer
Publicado: (1902)

The Treatment of Inoperable Cancer
Publicado: (1902)

Treatment of Inoperable Cancer
Publicado: (1915)

Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4mbdqog5s7ohr173sn3r5fu75n